Phase 3 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis
New England Journal of Medicine · 24.04.2025 · 392 (16) · 1569-1581
DOI: 10.1056/nejmoa2411664 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift New England Journal of Medicine, erschienen am 24.04.2025. Verfasst von James D Chalmers und 18 weiteren Autor:innen. Beteiligte Einrichtung: Division of Respiratory Medicine and Gastroenterology, University of Dundee, Dundee, United Kingdom. Hauptthemen laut MEDLINE: Bronchiectasis, Dipeptidyl-Peptidase IV Inhibitors. Die Arbeit wurde bisher 218-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: Insmed.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Respiratory Medicine and Gastroenterology, University of Dundee, Dundee, United Kingdom.
- Hôpital Cochin and Cystic Fibrosis National Reference Center, Service de Pneumologie, Assistance Publique-Hôpitaux de Paris, Paris.
- Université Paris Cité, INSERM Unité 1016-Institut Cochin, Paris.
- National Jewish Health, Denver.
- University of Colorado, Denver.
- Population and Health Sciences Institute, NIHR Biomedical Research Centre for Aging, Newcastle University, Newcastle upon Tyne, United Kingdom.
Förderung
- Insmed
Zitieren
APA
Chalmers, J. D., Burgel, P. R., Daley, C. L., De Soyza, A., Haworth, C. S., Mauger, D., Loebinger, M. R., McShane, P. J., Ringshausen, F. C., Blasi, F., Shteinberg, M., Mange, K., Teper, A., Fernandez, C., Zambrano, M., Fan, C., Zhang, X., Metersky, M. L., & ASPEN Investigators (2025). Phase 3 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis. New England Journal of Medicine, 392(16), 1569-1581. https://doi.org/10.1056/nejmoa2411664
Vancouver
Chalmers JD, Burgel PR, Daley CL, De Soyza A, Haworth CS, Mauger D, et al. Phase 3 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis. New England Journal of Medicine. 2025;392(16):1569-1581. doi:10.1056/nejmoa2411664
BibTeX
@article{Chalmers2025,
author = {Chalmers, James D and Burgel, Pierre-Régis and Daley, Charles L and De Soyza, Anthony and Haworth, Charles S and Mauger, David and Loebinger, Michael R and McShane, Pamela J and Ringshausen, Felix C and Blasi, Francesco and Shteinberg, Michal and Mange, Kevin and Teper, Ariel and Fernandez, Carlos and Zambrano, Migdalia and Fan, Chunpeng and Zhang, Xiangmin and Metersky, Mark L and ASPEN Investigators, ASPEN Investigators},
title = {Phase 3 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis},
journal = {New England Journal of Medicine},
year = {2025},
volume = {392},
number = {16},
pages = {1569--1581},
doi = {10.1056/nejmoa2411664}
}
EUVIMED